Hydroxychloroquine in systemic lupus erythematosus and rheumatoid arthritis and its safety in pregnancy

Author： Abarientos Crispin   Sperber Kirk   Shapiro Deborah L   Aronow Wilbert S   Chao Chun Peng   Ash Julia Y  

Publisher： Informa Healthcare

ISSN： 1474-0338

Source： Expert Opinion on Drug Safety, Vol.10, Iss.5, 2011-09, pp. : 705-714

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Frequency of Lymphadenopathy in Rheumatoid Arthritis and Systemic Lupus Erythematosus

By Çalgüneri M   Öztürk MA   Özbalkan Z   Akdogan A   Üreten K   Kiraz S   Ertenli I  

The Journal of International Medical Research, Vol. 31, Iss. 4, 2003-07 ,pp. : 345-349

Field House Publishing

Access to resources Recommend Favorite

Hydroxychloroquine: Cardiovascular disorders in patients with systemic lupus erythematosus: 2 case reports

By  

Reactions Weekly, Vol. 1, Iss. 1021, 2004-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Antimalarial Drugs in Systemic Lupus Erythematosus: Use in Pregnancy

By Borden M.B.   Parke A.L.  

Drug Safety, Vol. 24, Iss. 14, 2001-01 ,pp. : 1055-1063

Adis International

Access to resources Recommend Favorite

Leflunomide: Subacute cutaneous lupus erythematosus in a patient with rheumatoid arthritis: case report

By  

Reactions Weekly, Vol. 1, Iss. 1082, 2005-01 ,pp. : 16-17

Adis International

Access to resources Recommend Favorite

Rheumatoid Arthritis and Pregnancy: Safety Considerations in Pharmacological Management

By Makol Ashima   Wright Kerry   Amin Shreyasee  

Drugs, Vol. 71, Iss. 15, 2011-10 ,pp. : 1973-1987

Adis International

Access to resources Recommend Favorite